TrialJournal of acquired immune deficiency syndromes (1999)2016

Brief Report: Efficacy and Safety of Switching to a Single-Tablet Regimen of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide in HIV-1/Hepatitis B-Coinfected Adults.

Joel Gallant et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.